switching back to semaglutide from tirzepatide Tirzepatide: Reasons, Safety & Dosage for Weight Loss Switching from semaglutide → tirzepatide:

Semaglutide is licensed for use with other glucose-lowering medicines including insulin (MHRA/EMC SmPC), and NICE guidelines (NG28) support GLP-1 receptor agonist use with insulin in specific circumstances

Not intended for diagnosis, treatment, cure, or prevention of any disease

Study its mechanism of action in the regulation of intestinal flora and the communication of the gut-brain axis

7+ week program* Whats Included : All required supplies Patient-specific dosing Nutritional guidelines Unlimited support * Duration of each program will vary and is based on frequency of the personalized dosing schedule

Yes from $249/month covers any prescribed dose, with no surprise step-ups as you titrate